Xiaoni Shao
Overview
Explore the profile of Xiaoni Shao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
196
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amatjan M, Li N, He P, Zhang B, Mai X, Jiang Q, et al.
Drug Des Devel Ther
. 2023 Jan;
17:107-128.
PMID: 36712944
Background: L. formula (CILF) is a traditional Chinese medicine (TCM) widely used in the treatment of gout and hyperuricemic nephropathy (HN). The aim of this research was to investigate the...
2.
Li N, Amatjan M, He P, Wu M, Yan H, Shao X
PLoS One
. 2022 Dec;
17(12):e0276591.
PMID: 36534664
Hyperuricaemic nephropathy (HN) is a common clinical complication of hyperuricaemia (HUA) and poses a huge threat to human health. Hence, we aimed to prospectively investigate the dysregulated genes, pathways and...
3.
Li N, Amatjan M, He P, Zhang B, Mai X, Jiang Q, et al.
Pharm Biol
. 2022 Nov;
60(1):2338-2354.
PMID: 36444935
Context: L. (Asteraceae) formula (CF) has been applied as a folk medicine to treat hyperuricemic nephropathy (HN). However, the exact mechanism remains unclear. Objective: To explore the therapeutic effect and...
4.
He H, Shao X, Li Y, Gihu R, Xie H, Zhou J, et al.
Front Pharmacol
. 2021 Jun;
12:675675.
PMID: 34135756
Malignant tumors remain the health problem of highest concern among people worldwide due to its high mortality and recurrence. Lung, gastric, liver, colon, and breast cancers are among the top...
5.
Zuo Z, Chen M, Shao X, Qian X, Liu X, Zhou X, et al.
Bioorg Med Chem Lett
. 2020 Jan;
30(4):126855.
PMID: 31898998
A series of novel tetrahydropyridine derivatives were prepared and evaluated using cell-based measurements. Systematic optimization of general structure G-1 led to the identification of compound 35 (EC = 4.9 nM)...
6.
Li Y, Wang C, Li D, Deng P, Shao X, Hu J, et al.
Oncol Rep
. 2017 Sep;
38(5):3044-3054.
PMID: 28901465
Lung metastasis is an important cause for the low 5-year survival rate of colorectal cancer patients. Understanding the metabolic profile of lung metastasis of colorectal cancer is important for developing...
7.
Shao X, Lu W, Gao F, Li D, Hu J, Li Y, et al.
J Neurosci
. 2016 Nov;
36(43):10990-11005.
PMID: 27798180
Significance Statement: This work demonstrates that a high-uric acid (UA) diet triggers the expression of proinflammatory cytokines, activates the Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB pathway, and increases gliosis in...
8.
Lu W, Xu Y, Shao X, Gao F, Li Y, Hu J, et al.
Sci Rep
. 2015 Jul;
5:12144.
PMID: 26179594
Epidemiological studies have shown that an elevated uric acid (UA) level predicts the development of metabolic syndrome and diabetes; however, there is no direct evidence of this, and the underlying...
9.
Wang H, Wang L, Zhang H, Deng P, Chen J, Zhou B, et al.
Mol Cancer
. 2013 Oct;
12(1):121.
PMID: 24138801
Background: Rectal cancer is one of the most prevalent tumor types. Understanding the metabolic profile of rectal cancer is important for developing therapeutic approaches and molecular diagnosis. Methods: Here, we...
10.
Wang L, Chen J, Chen L, Deng P, Bu Q, Xiang P, et al.
Mol Cancer
. 2013 Apr;
12:25.
PMID: 23556477
Background: The biomarker identification of human esophageal cancer is critical for its early diagnosis and therapeutic approaches that will significantly improve patient survival. Specially, those that involves in progression of...